Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More
Wednesday, February 21, 2018
Cognoa’s AI platform for autism diagnosis gets first FDA stamp
Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance. Read More
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment